Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 12 , ISSUE 6 ( November-December, 2020 ) > List of Articles


TORCH Infection and Its Influence on High-risk Pregnancy

Smriti Baghel, Saunitra A Inamdar

Keywords : High-risk pregnancy, Perinatal outcome, Seronegativity, Seropositivity, TORCH

Citation Information : Baghel S, Inamdar SA. TORCH Infection and Its Influence on High-risk Pregnancy. J South Asian Feder Obs Gynae 2020; 12 (6):376-382.

DOI: 10.5005/jp-journals-10006-1840

License: CC BY-NC 4.0

Published Online: 12-04-2021

Copyright Statement:  Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.


Introduction: Toxoplasmosis, other agents, rubella, cytomegalovirus, and herpes simplex virus (TORCH) infections are important groups of organisms which are initially inapparent, asymptomatic, and difficult to diagnose on the clinical ground during pregnancy but have the potential to cause bad obstetrical outcomes. The aim was to study the association of TORCH infection with the perinatal outcome in cases of high-risk pregnancies. Materials and methods: A total of 200 high-risk pregnant patients of age group <35 years attending Antenatal Care Outpatient Department or admitted in Inpatient Department of Obstetrics and Gynaecology Department at Acharya Vinoba Bhave Rural Hospital, Sawangi, were included in the present study. The study group includes high-risk pregnant women with fetal congenital anomalies, recurrent pregnancy loss, oligohydramnios, intrauterine fetal death, fetal growth restriction, hypertensive disorders, bad obstetric history, preterm labor, polyhydramnios, and other medical disorders. Patient\'s serum was analyzed for IgG (immunoglobulin G) and IgM (immunoglobulin M) antibodies against TORCH agents using ELISA kit and followed till delivery for the perinatal outcome. Perinatal outcome in high-risk pregnant women with seropositivity and seronegativity was compared. Results: In 200 cases of high-risk pregnancy, the majority of women with seropositivity for TORCH infection were of younger age group with low parity, residing over rural areas and of low socioeconomic status. One hundred sixty-two cases (81%) were seropositive and 38 cases (19%) were seronegative for TORCH antibodies. The seropositivity in high-risk pregnant women for toxoplasma, rubella, cytomegalovirus, and herpes was 5.5, 75.5, 56, and 14.5%, respectively for IgG, while it was 0, 6, 4, and 0% for IgM, respectively. Our study showed that pregnant patients with high-risk factors for TORCH infection with seropositivity showed a significant association with adverse perinatal outcomes. Conclusion: Association of seropositivity with high-risk factors for TORCH infection was found to be associated with adverse perinatal outcome as compared to seronegativity in same high-risk groups.

PDF Share
  1. Kumar R, Binnani A and Shyoran S. Seroprevalence of TORCH infections in pregnant women with bad obstetric history in and around Bikaner, Northern Western Rajasthan. J Appl Med Sci 2018;6(5):2018–2023. DOI: 10.21276/sjams.2018.6.5.30.
  2. Singh G, Sidhu K. Bad obstetric history: a prospective study. Med J Armed Forces India 2010;66(2):117–120. DOI: 10.1016/s0377-1237(10)80121-2.
  3. Pradeep MK, Gnanadeep NV, Umesh RD, et al. Prevalence of high risk pregnancy in rural Dharwad. IOSR J Dent Med Sci 2015;10:29–32.
  4. Rajani M. Serological profile of TORCH infection among antenatal women at a Tertiary Care Center in North India. J Pure Appl Microbiol 2018;12(4): 2305–2311.
  5. Montoya JG, Remington JS. Toxoplasma gondii. In: Mandel GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennetts’ principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000, pp. 2858–2888.
  6. Jones J, Lopez A, Wilson M. Congenital toxoplasmosis. Am Fam Physician 2003;67:2131–2138.
  7. Ramesh V, Pardeep K, Suraj C. Rubella vaccine: new horizon in prevention of congenital rubella syndrome in the India. Hum Vaccines Immuno Ther 2012;8(6):831–833. DOI: 10.4161/hv.19584.
  8. Lee JY, Bowden DS. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev 2000;13:571–587. DOI: 10.1128/CMR.13.4.571.
  9. Fowler KB, Pass RF. Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity. Pediatrics 2006;118:e286–e292. DOI: 10.1542/peds.2005-1142.
  10. Al-Hareth Z, Monem F, Abdel Megiud N. Is low birth weight a risk indicator for congenital cytomegalovirus infection? J Infect Dev Countries 2010;4:44–47. DOI: 10.3855/jidc.539.
  11. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007;17:355–363. DOI: 10.1002/rmv.544.
  12. Elena A, Daniela F, Monica M, et al. Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention. Virol J 2009;6:40. DOI: 10.1186/1743-422X-6-40.
  13. Marco C, Massimo G. The importance of diagnosing genital herpes. J Antimicrob Chemother 2001;47:9–16.
  14. Serdar U. Genital herpes in pregnancy. Accessed 18 November 2011.
  15. O'Riordan DP, Golden WC, Aucott SW. Herpes simplex virus infections in preterm infants. Pediatrics 2006;118(6):e1612–e1620. DOI: 10.1542/peds.2005-1228.
  16. Brown ZA, Benedetti J, Ashley R, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. New Engl J Med 1991;324(18):1247–1252. DOI: 10.1056/NEJM199105023241804.
  17. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. New Engl J Med 1997;337(8):509–515. DOI: 10.1056/NEJM199708213370801.
  18. Biswas D, Borkakoty B, Mahanta J, et al. Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India. BMC Infect Dis 2011;11:325. DOI: 10.1186/1471-2334-11-325.
  19. Pundit S, Gupte S, Sheriar N, et al. Screening and management of TORCH in pregnancy. Consensus Group meeting, 2014, pp. 1–6.
  20. Prasoona KR, Srinadh B, Sunitha T, et al. Seroprevalence and influence of torch infections in high risk pregnant women: a large study from South India. J Obstet Gynaecol India 2015;65(5):301–309. DOI: 10.1007/s13224-014-0615-3.
  21. Turbadkar D, Mathur M, Rele M. Seroprevalence of torch infection in bad obstetric history. Indian J Med Microbiol 2003;21:108–110.
  22. Pradhan SV. Epidemiological and serological profiles of TORCH infection in pregnancy. J Pathol Nepal 2015;5:705–708. DOI: 10.3126/jpn.v5i9.13690.
  23. Padmavathy M, Gowri M, Malini J, et al. Seroprevalence of TORCH infections and adverse reproductive outcome in current pregnancy with bad obstetric history. J Clin Biomed Sci 2013;3(2):62–71.
  24. Vilibie-Cavlek T, Ljubin-Sternak S, Ban M, et al. Seroprevalence of TORCH infection in women of child bearing age in Croatia. J Matern Fetal Neonatal Med 2010;24(2):280–283. DOI: 10.3109/14767058.2010.485233.
  25. Sarkar MD, Anuradha B, Sharma N, et al. Seropositivity of toxoplasmosis in antenatal women with bad obstetric history in a Tertiary-care Hospital of Andhra Pradesh, India. J Health Popul Nutr 2012; 30(1): 87–92. DOI: 10.3329/jhpn.v30i1.11287.
  26. Mohammad EAK, Salman YJ. Study of TORCH infections in women with Bad Obstetric History (BOH) in Kirkuk city. Int J Curr Microbiol Appl Sci 2014;3(10):700–709.
  27. Surpam RB, Kamlakar UP, Khadse RK, et al. Serological study for TORCH infections in women with bad obstetric history. J Obstet Gynecol India 2006;56(1):41–43.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.